Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Metoprolol Succinate Combined With Trimetazidine in Reducing Inflammatory Biomarkers and Improving Clinical Outcomes in Coronary Heart Disease With Angina Pectoris

NCT07074834 is registered in ClinicalTrials.gov with Shiyan City Renmin Hospital as lead sponsor.

NCT NCT07074834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Metoprolol Succinate Combined With Trimetazidine in Reducing Inflammatory Biomarkers and Improving Clinical Outcomes in Coronary Heart Disease With Angina Pectoris
Lead sponsor
Shiyan City Renmin Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
December 31, 2022
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease (chd)